Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Clinical Lung Cancer|April 4, 2015
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platformDavid R Gandara, Philip C Mack, Carol Bult, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP StudyPhilip C Mack, Mary W Redman, Hanna Tukachinsky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 8, 2025
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging DatabaseDavid P Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2016
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016Daniel S W Tan, Sue S Yom, Ming S Tsao, et al.
Cancer Cell|October 20, 2023
Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancerAnanda M Rodilla, Rajesh M Valanparambil, Philip C Mack, et al.
Vaccines|July 27, 2024
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung CancerPhilip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Pageof 13